← 홈

프로그램 비교

타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일

현재 선택: 1개 · 임상 갱신 필요 1개

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

프로그램 선택

API CSV18행 · 1개 프로그램
OverviewToxicologyClinical

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
CGTStandard DatabasestalePhase 2
Goserelin Acetate (Goserelin Acetate)
Mayo Clinic·Prostate Adenocarcinoma
32 trials
Overview
Program
Goserelin Acetate
Overview
Company
Mayo Clinic
Overview
Modality
CGT
Overview
Target
Prostate Adenocarcinoma
Overview
Indication
Prostate Adenocarcinoma; Prostate Carcinoma
Overview
Phase
PHASE_2
Overview
Status
ACTIVE
Overview
Content status
Standard Database
Overview
Data Confidence
Data Confidence · Medium
Overview
Development Signal
Development Signal · Emerging
Overview
Approval status
Investigational
Toxicology
Major finding
Multicenter, prospective, single-arm clinical study to investigate the efficacy and safety of Zoladex (Goserelin acetate) 10.8 mg prior to surgery in Chinese premenopausal women with symptomatic uterine fibroids.. To assess the effect and safety of Zoladex (Goserelin acetate) 10.8 mg in patients with uterine fibroids. Fifty-three patients received Goserelin acetate 10.8 mg onc…
Clinical
Safety signal
Multicenter, prospective, single-arm clinical study to investigate the efficacy and safety of Zoladex (Goserelin acetate) 10.8 mg prior to surgery in Chinese premenopausal women with symptomatic uterine fibroids.. To assess the effect and safety of Zoladex (Goserelin acetate) 10.8 mg in patients with uterine fibroids. Fifty-three patients received Goserelin acetate 10.8 mg onc…
Clinical
Selected reported efficacy
ORR 31%
Clinical
Reported ORR
31%
Clinical
Result source
ClinicalTrials.gov NCT00432172
Clinical
Program phase
PHASE_2
Clinical
Trial ref
NCT00432172